Short answer · Medically reviewed summary · Last updated: 2026-04-07
The primary treatment for Xeroderma Pigmentosum is rigorous, lifelong protection from all sources of ultraviolet (UV) radiation to prevent DNA damage and subsequent skin cancers. First-Line Protection and Medical Management Because individuals with Xeroderma Pigmentosum lack the ability to repair UV-induced DNA mutations, strict photoprotection is the cornerstone of therapy. This involves the use of high-SPF broad-spectrum sunscreens, UV-blocking clothing, wide-brimmed hats, and specialized UV-opaque films on windows in homes, schools, and vehicles.
2 people with Xeroderma Pigmentosum have shared their first-person experience on this question at DiseaseMaps.
What are the best treatments for Xeroderma Pigmentosum?
Treatments for Xeroderma Pigmentosum: what real patients say works for them, alongside a medically reviewed overview citing sources like NIH GARD and Orphanet.
The primary treatment for Xeroderma Pigmentosum is rigorous, lifelong protection from all sources of ultraviolet (UV) radiation to prevent DNA damage and subsequent skin cancers.
First-Line Protection and Medical Management
Because individuals with Xeroderma Pigmentosum lack the ability to repair UV-induced DNA mutations, strict photoprotection is the cornerstone of therapy. This involves the use of high-SPF broad-spectrum sunscreens, UV-blocking clothing, wide-brimmed hats, and specialized UV-opaque films on windows in homes, schools, and vehicles. While there is no cure, topical medications such as 5-fluorouracil (Efudex) or imiquimod (Aldara) are often prescribed to treat actinic keratoses and prevent the progression of superficial skin cancers.
Surgical and Non-Pharmacological Interventions
Surgical excision remains the standard for removing basal cell and squamous cell carcinomas, which occur with high frequency in patients with Xeroderma Pigmentosum. Dermatologists must perform frequent full-body skin examinations—often every three to six months—to identify and treat lesions early. In cases of significant ocular involvement, ophthalmologists may perform corneal transplants or manage chronic conjunctival inflammation. Occupational therapy can assist families in adapting living environments to minimize UV exposure while maintaining a high quality of life.
Multidisciplinary Care and Emerging Research
Effective management of Xeroderma Pigmentosum requires a multidisciplinary team, typically including a dermatologist, ophthalmologist, neurologist, clinical geneticist, and an oncologist. Because the disease is highly heterogeneous, treatment effectiveness varies significantly based on the specific genetic complementation group (A through G or variant). Emerging research is focused on gene therapy and DNA repair enzyme delivery systems, though these remain in experimental phases. Clinical trials are currently investigating the use of oral retinoids (such as isotretinoin) as chemopreventive agents to reduce the rate of new tumor development.
Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice. Treatment plans for Xeroderma Pigmentosum must be personalized by your medical team based on your specific genetic subtype and clinical presentation. Never adjust medications or treatment protocols without consulting your physician.
References
- NIH Genetic and Rare Diseases Information Center (GARD): Xeroderma pigmentosum
- Orphanet: Xeroderma pigmentosum (ORPHA914)
- Xeroderma Pigmentosum Society (XPS)
- OMIM (Online Mendelian Inheritance in Man): Xeroderma pigmentosum group A
Posted Oct 12, 2018 by Teddington Trust
Sitting in the shade
Posted Jul 26, 2017 by Debbie law 1100
